Malmö Treatment Referral and Intervention Study
MATRIS
1 other identifier
interventional
79
1 country
1
Brief Summary
This study aims to study and implement active referral of heroin users from a syringe exchange programme to evidence-based treatment for heroin addiction. Patients are randomized to either a strength-based case management intervention or a control group, while both groups receive referral to medical investigation for inclusion in substitution treatment for heroin addiction. The hypothesis is that syringe exchange can be used for referral to effective treatment, and that a strength-based intervention can increase the number of patients who are successfully referred and enter treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
October 18, 2011
CompletedFirst Posted
Study publicly available on registry
October 24, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2013
CompletedNovember 25, 2014
November 1, 2014
1.5 years
October 18, 2011
November 24, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Treatment entry in substitution treatment at two time points - directly after referral and after up to 3 months
Percentage of patients successfully referred for examination and start of substitution treatment. This is measured at two time points, at 10 days post-referral when the medical examination is carried out (the percentage of patients who successfully show up) and subsequently the patients will be followed up to three months post-referral with respect to actual initiation of medication.
At medical examination after 10 days, and subsequently for up to 3 months
Secondary Outcomes (1)
Retention and treatment outcome in substitution treatment
3, 6, 12, 24, 26 months
Study Arms (2)
Strength-based case management
EXPERIMENTALCase management plus referral (vs referral-only)
Referral only
ACTIVE COMPARATORReferral only (no case management intervention)
Interventions
Strength-based case management
Eligibility Criteria
You may qualify if:
- Registered at syringe exchange programme of Malmö
- Primary drug heroin
- Heroin dependence
- Living in catchment area for substitution treatment of Addiction Centre Malmö
You may not qualify if:
- Inability to understand consent and information
- Unstable psychiatric condition making treatment regulations impossible
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
- Swedish Council for Working Life and Social Researchcollaborator
Study Sites (1)
Malmö Addiction Centre, Malmö University Hospital entrance 90
Malmo, 205 02, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2011
First Posted
October 24, 2011
Study Start
October 1, 2011
Primary Completion
April 1, 2013
Study Completion
April 1, 2013
Last Updated
November 25, 2014
Record last verified: 2014-11